Abstract
Purpose
To explore whether anxiety and depression are prognostic indexes for overall survival in patients with nasopharyngeal carcinoma (NPC) who underwent intensity-modulated radiotherapy (IMRT).
Methods
Clinical data were collected for NPC patients who underwent IMRT. Anxiety and depression were investigated before radiotherapy by using the Hospital Anxiety and Depression Scale (HADS). The survival rate was calculated by the Kaplan-Meier method, and survival curves were compared among patients with different levels of anxiety and depression. The Cox risk regression model was used to screen the factors affecting survival.
Results
A total of 390 initially treated NPC patients were included in the study. Among them, 166 patients suffered from anxiety, and 95 patients suffered from depression before radiotherapy. The 5-year overall survival rates for patients with and without anxiety before radiotherapy were 71.6% and 81.8% (χ2 = 5.31, P = 0.021), respectively. The 5-year overall survival rates for patients with and without depression before radiotherapy were 74.3% and 78.1% (χ2 = 0.05, P = 0.82), respectively. Cox regression analysis indicated clinical stages (HR = 3.982, 95% CI: 2.365~6.705), anxiety (HR = 1.832, 95% CI: 1.140~2.944), and gender (HR = 0.555, 95% CI: 0.313~0.984) as independent prognostic factors.
Conclusion
Anxiety before radiotherapy is associated with poor prognosis in NPC patients.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00520-021-06130-y/MediaObjects/520_2021_6130_Fig1_HTML.png)
Similar content being viewed by others
Data availability
The datasets used or analyzed in the current study are available from the corresponding authors on reasonable request.
Abbreviations
- NPC:
-
Nasopharyngeal carcinoma
- IMRT:
-
Intensity-modulated radiotherapy
- HADS:
-
Hospital Anxiety and Depression Scale
- GTV:
-
Gross tumor volume
- CTV:
-
Clinical tumor volume
- PTV:
-
Planning target volume
- DDP:
-
Cisplatin
- OS:
-
Overall survival
References
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet 394(10192):64–80
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP, MAC-NPC Collaborative Group (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: An update of the MAC-NPC meta-analysis. Lancet Oncol 16(6):645–655
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y (2015) Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncol 51(11):1041–1046
McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, Ezzat S, Pothier D, Bernstein LJ, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J (2018) Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 102(2):340–352
Ghiggia A, Castelli L, Riva G, Tesio V, Provenzano E, Ravera M, Garzaro M, Pecorari G, Franco P, Potenza I, Rampino M, Torta R (2017) Psychological distress and coping in nasopharyngeal cancer: An explorative study in Western Europe. Psychol Health Med 22(4):449–461
Deng YT, Zhong WN, Jiang Y (2014) Measurement of distress and its alteration during treatment in patients with nasopharyngeal carcinoma. Head Neck 36(8):1077–1086
Qin L, Mo YL, Li L, Wei ZJ, Zhu XD, Yin X, Wei Q (2015) Sleep characteristics and psychological symptoms in patients with locally advanced nasopharyngeal carcinoma before and after intensity-modulated radiotherapy and concurrent chemotherapy. Psychol Health Med 20(6):662–669
Wang X, Lv Y, Li W, Gan C, Chen H, Liu Y, Chao HH, Li CR, Cheng H (2018) Correlation between psychosocial distress and quality of life in patients with nasopharyngeal carcinoma following radiotherapy. J Oncol 2018:1–4
Chida Y, Hamer M, Wardle J, Steptoe A (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 5(8):466–475
Satin JR, Linden W, Phillips MJ (2009) Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer 115(22):5349–5361
Lazure KE, Lydiatt WM, Denman D, Burke WJ (2009) Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. Head Neck 31(7):888–892
van den Berg MG, Rütten H, Rasmussen-Conrad EL, Knuijt S, Takes RP, van Herpen CM, Wanten GJ, Kaanders JH, Merkx MA (2014) Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: A cross-sectional study. Head Neck 36(1):60–65
Chen AM, Hsu S, Felix C, Garst J, Yoshizaki T (2018) Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation. Laryngoscope 128(3):641–645
Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR (2018) Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study. Psychooncology 27(9):2245–2256
Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008) Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26(16):2754–2760
de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA (2001) Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37(3):332–339
Liu SA, Tsai WC, Wong YK, Lin JC, Poon CK, Chao SY, Hsiao YL, Chan MY, Cheng CS, Wang CC, Wang CP (2006) Nutritional factors and survival of patients with oral cancer. See comment in PubMed Commons below Head Neck 28(11):998–1007
Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial. Lancet Oncol 17(11):1509–1520
Chen YP, Guo R, Liu N, Liu X, Mao YP, Tang LL, Zhou GQ, Lin AH, Sun Y, Ma J (2015) Efficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis of randomized controlled trials. J Cancer 6(9):883–892
Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, Peng J, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C (2016) Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: A multicentre, randomised, open-label, phase 3 trial. Lancet 388(10054):1883–1892
Tan T, Lim WT, Fong KW, Cheah SL, Soong YL, Ang MK, Ng QS, Tan D, Ong WS, Tan SH, Yip C, Quah D, Soo KC, Wee J (2015) Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: A randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 91(5):952–960
Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370
Smarr KL, Keefer AL (2011) Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 63(Suppl 11):S454–S466
Julian LJ (2011) Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 63(Suppl 11(0 11)):S467–S472
Lutgendorf SK, Sood AK, Antoni MH (2010) Host factors and cancer progression: Biobehavioral signaling pathways and interventions. J Clin Oncol 28(26):4094–4099
Irwin MR, Olmstead RE, Ganz PA, Haque R (2013) Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun 30:S58–S67
Husson O, Nieuwlaat WA, Oranje WA, Haak HR, van de Poll-Franse LV, Mols F (2013) Fatigue among short- and long-term thyroid cancer survivors: Results from the population-based profiles registry. Thyroid 23(10):1247–1255
Kim SA, Roh JL, Lee SA, Lee SA, Kim SW, Choi SH, Nam SY, Kim SY (2016) Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer. Cancer 122(1):131–140
De Boer MF, Ryckman RM, Pruyn JF, Van den Borne HW (1999) Psychosocial correlates of cancer relapse and survival: A literature review. Patient Educ Couns 37(3):215–230
Hong JS, Tian J, Han QF, Ni QY (2015) Quality of life of nasopharyngeal cancer survivors in China. Curr Oncol 22(3):142–147
Liu AH, He AB, Tong WX, Peng XL, Tian Q, Wang H, Li XG, Xu HL (2016) Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy. Cancer Radiother 20(5):384–390
Code availability
Not applicable.
Author information
Authors and Affiliations
Contributions
Weijian Zhang and Jinsheng Hong contributed to the idea and design of the study; Jinmei Chen, Yangjingling Hua, Li Su, Caihong Wang, Hairong Zhang, Jinru Ye, Xiurong Song, and Rong Li performed the data collection; Jinmei Chen and Yangjingling Hua performed the data analyses and wrote the manuscript; Jun Tian helped perform the statistical analysis.
Corresponding author
Ethics declarations
Ethics approval
The study protocol was approved by the relevant institutional review boards for human research at the First Affiliated Hospital of Fujian Medical University.
Consent to participate
Written informed consent was obtained from all participants.
Consent for publication
All authors have read and agreed to the published version of the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, J., Hua, Y., Su, L. et al. The effect of psychological condition before radiotherapy on prognosis in 390 patients initially treated for nasopharyngeal carcinoma. Support Care Cancer 29, 5967–5972 (2021). https://doi.org/10.1007/s00520-021-06130-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06130-y